Description

A Working Group of the American Academy of Dermatology classified the severity of psoriatic arthritis based on its clinical impact and therapeutic requirements.


 

Parameters:

(1) therapeutic requirements

(2) disability

 

Therapy

Disability

Severity

adequate response to NSAIDS

none to minimal

mild

disease modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) blocker; does not respond to NSAIDS

affects activities of daily living (ADL); some impairment of mental function and/or physical function

moderate

DMARDs AND (TNF blockers or other biologic therapies); does not respond to monotherapy

unable to perform activities of daily living; significant impairment of mental and/or physical function

severe

 


To read more or access our algorithms and calculators, please log in or register.